IREN enters September with bears fully re-entrenched after the earnings disappointment, the borrow pool at its tightest in a year, and analysts holding price targets that imply more than double the current price — a gap the market is making clear it does not believe.
The positioning story has hardened since the August 27 print. Short interest has rebuilt to 103.9 million shares, representing 36.6% of the free float — up 4% on the week and 9% over the past month. That fully reverses the pre-earnings trimming flagged in earlier notes and puts the short base at a 30-day high. Bears who lightened ahead of the catalyst have returned. The borrow market confirms it: availability has collapsed to just 0.435%, down 71% on the week and equal to the 52-week floor. For every share still available to borrow, more than 200 are already out on loan. Cost to borrow has edged higher too, up nearly 12% on the week to 1.24%, though it remains low in absolute terms — this is entrenched inventory, not a fresh panic short. The ORTEX short score has crept to 69.3, its highest reading in the 10-day history shown, and ranks in the bottom 6th percentile of the universe. The borrow pool, by every measure, is as sealed as it has been all year.
Options positioning now diverges sharply from the short side. The put/call ratio has dropped to 0.71, more than one standard deviation below its 20-day average of 0.78. That is a meaningful shift from the defensive hedging mood seen in late July, when the PCR ran above 1.05. Options traders are reaching for calls rather than puts — a contrast worth noting given how aggressively shorts have rebuilt in the same window.
The Street is holding its ground on the bull case despite the post-earnings drop. Multiple analysts reiterated buy-equivalent ratings this week: BTIG held its $80 target, Macquarie and HC Wainwright both maintained $90 targets, and Cantor Fitzgerald stuck at $99. The mean price target of $77.84 implies roughly 111% upside from the current $36.82 close. The bull case rests on the NVIDIA partnership and the Mirantis acquisition — a pivot toward high-margin AI cloud services that bulls argue the market is mispricing. Bears counter that the winding-down of BTC mining, regulatory exposure, and power-supply bottlenecks will weigh on near-term profitability. The EPS momentum factor scores of 11 (30-day) and 3 (90-day) sit near the bottom of the universe, and EPS surprise at 95th percentile reflects backward-looking beats that the forward estimates — still deeply negative — do not support. The analyst recommendation divergence score at the 95th percentile captures the tension precisely: the sell-side is bullish, but the positioning data tells a different story.
The institutional register adds one notable development. Goldman Sachs filed a Schedule 13G on August 12, disclosing a 9.4% stake — 33.6 million shares as of that filing. Bank of America separately filed a 13G on August 3 at 5.8%. Both are passive disclosures, not activist 13Ds, but the sheer size of the Goldman position at 9.4% makes it the largest disclosed stake on the register. As always with 13D/G filings, stakes reflect the position at the time of disclosure, and holders dropping below the 5% threshold may exit without a further filing.
Peers provide little comfort on the price-action front. CORZ fell 10.9% on the week, CLSK dropped 13.3%, and RIOT led the group lower at -16.5%. IREN's -12.8% decline sits roughly in the middle of the peer distribution — neither holding up nor leading the selloff. The sector is under broad pressure, and IREN carries the additional weight of the most compressed borrow pool in the group.
The next earnings event is not until November 6, leaving two full months for the tug-of-war between a historic short base and a bullish analyst consensus to play out in the open market — with no catalyst to resolve it cleanly in either direction.
See the live data behind this article on ORTEX.
Open IREN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.